MISSION

Science
that becomes medicine

VISION

PrimeCell team is working 15 years to discover technologies
to treat unmedical needs of civilisation.

STRATEGY

PrimeCell is the bio-med company focusing on discovering and clinical testing of biological drugs and medicinal technologies, which are changing genes and cells parameters to support regeneration of human tissues and organs.

We are proud to our results
in regenerative medicine

Patients/year

SQM OF OUR LABS

RESEARCH PROJECTS

CORE EMPLOYEES

RESEARCH PLATFORM

NEWS

Selekce a diagnostika spermií v dalším patentovém řízení

Společnost Primecell spolu s partnery podala 17. ledna 2021 dvě patentové přihlášky, týkající se nové metody selekce a diagnostiky spermií, a to jak pro veterinární, tak pro humánní použití. Tyto[…]

Read more

Latest publication published by Serhiy Forostyak, MD, PhD, CSO: Transplantation of Neural Precursors Derived from Induced Pluripotent Cells Preserve Perineuronal Nets and Stimulate Neural Plasticity in ALS Rats

A promising therapeutic strategy for amyotrophic lateral sclerosis (ALS) treatment is stem cell therapy. Neural progenitors derived from induced pluripotent cells (NP-iPS) might rescue or replace dying motoneurons (MNs). However,[…]

Read more

Rada pro komercializaci Ostravské univerzity – Michal Zahradníček byl jmenován novým členem

Zakladatel společnosti Primecell Bioscience, Ing. Michal Zahradníček, MBA, byl rektorem Ostravské univerzity jmenován členem její Rady pro komercializaci. Rada, která má 11 členů, je poradním sborem rektora v oblasti komercializace[…]

Read more

Co-operative transfer research

PrimeCell leads co-operative transfer research with prestigious Universities, Science institutions and technology companies around the world.